Sandra E. Dillahunt

Array ( [id] => 13249129 [patent_doc_number] => 10137236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Self-regulating device for modulating inflammation [patent_app_type] => utility [patent_app_number] => 14/301734 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 41 [patent_no_of_words] => 17705 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14301734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774790 [patent_doc_number] => 20160120946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'COMPOSITIONS COMPRISING GC-MACROPHAGE ACTIVATING FACTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/893354 [patent_app_country] => US [patent_app_date] => 2014-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12532 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17890755 [patent_doc_number] => 11453708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Designed ankyrin repeat proteins binding to hepatocyte growth factor [patent_app_type] => utility [patent_app_number] => 14/891792 [patent_app_country] => US [patent_app_date] => 2014-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 18315 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14057913 [patent_doc_number] => 10233240 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-03-19 [patent_title] => Methods for treating cholestatic liver fibrosis [patent_app_type] => utility [patent_app_number] => 14/279245 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 25 [patent_no_of_words] => 21321 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14279245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11009780 [patent_doc_number] => 20160206732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/891351 [patent_app_country] => US [patent_app_date] => 2014-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23023 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657279 [patent_doc_number] => 20140228284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/261641 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12871 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657283 [patent_doc_number] => 20140228288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/261602 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12840 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945820 [patent_doc_number] => 20140348841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'ANTI-GITR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/261152 [patent_app_country] => US [patent_app_date] => 2014-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22415 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10722437 [patent_doc_number] => 20160068583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'Interleukin-10 Compositions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/779928 [patent_app_country] => US [patent_app_date] => 2014-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 43751 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10911698 [patent_doc_number] => 20140314715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Sjogren\'s Syndrome' [patent_app_type] => utility [patent_app_number] => 14/258124 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9995 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11860103 [patent_doc_number] => 09739784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Giant obscurins and uses thereof in cancer prognosis and therapy' [patent_app_type] => utility [patent_app_number] => 14/221755 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 33 [patent_no_of_words] => 11492 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13636999 [patent_doc_number] => 09845456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-19 [patent_title] => Composition containing complex cytokines derived from EBV-infected B cells for inducing the maturation of dendritic cells [patent_app_type] => utility [patent_app_number] => 14/220138 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 4739 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735948 [patent_doc_number] => 20140271660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST ANTITHROMBIN BETA' [patent_app_type] => utility [patent_app_number] => 14/214267 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12064 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706862 [patent_doc_number] => 20160053009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'MELATONIN MONOCLONAL ANTIBODY, DETECTION, METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/775351 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20214 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905227 [patent_doc_number] => 20140308239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/209605 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29775 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568721 [patent_doc_number] => 20140186435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR (STNF-R) USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 14/199781 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17378179 [patent_doc_number] => 11236176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-01 [patent_title] => Serpinf2-binding molecules and method of use thereof [patent_app_type] => utility [patent_app_number] => 14/198804 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 25 [patent_no_of_words] => 10325 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568720 [patent_doc_number] => 20140186434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'ANTI-TUMOR NECROSIS FACTOR ALPHA (TNF-A) ANTIBODY USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 14/199736 [patent_app_country] => US [patent_app_date] => 2014-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813058 [patent_doc_number] => 20150025004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'KIDNEY FUNCTION BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 14/190237 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8928 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537182 [patent_doc_number] => 20140161829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'ANTIBODY-ACTIVE AGENT CONJUGATES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/181648 [patent_app_country] => US [patent_app_date] => 2014-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30765 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14181648 [rel_patent_id] =>[rel_patent_doc_number] =>)